Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 358

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction

Open access
Puymirat, Etienne, Cayla, Guillaume, Simon, Tabassome, Steg, Philippe G., Montalescot, Gilles, Durand-Zaleski, Isabelle, le Bras, Alicia, Gallet, Romain, Khalife, Khalife, Morelle, Jean-François, Motreff, Pascal, Lemesle, Gilles, Dillinger, Jean-Guillaume, Lhermusier, Thibault, Silvain, Johanne, Roule, Vincent, Labèque, Jean-Noel, Rangé, Grégoire, Ducrocq, Grégory, Cottin, Yves, Blanchard, Didier, Charles Nelson, Anaïs, De Bruyne, Bernard, Chatellier, Gilles, Danchin, Nicolas · 2021 · New England Journal of Medicine

Abstract

BACKGROUND: In patients with ST-elevation myocardial infarction (STEMI) who have multivessel disease, percutaneous coronary intervention (PCI) for nonculprit lesions (complete revascularization) is superior to treatment of the culprit lesion alone. However, whether complete revascularization that is guided by fractional flow reserve (FFR) is superior to an angiography-guided procedure is unclear. METHODS: In this multicenter trial, we randomly assigned patients with STEMI and multivessel disease who had undergone successful PCI of the infarct-related artery to receive complete revascularization guided by either FFR or angiography. The primary outcome was a composite of death from any cause, nonfatal myocardial infarction, or unplanned hospitalization leading to urgent revascularization at 1 year. RESULTS: The mean (±SD) number of stents that were placed per patient for nonculprit lesions was 1.01±0.99 in the FFR-guided group and 1.50±0.86 in the angiography-guided group. During follow-up, a primary outcome event occurred in 32 of 586 patients (5.5%) in the FFR-guided group and in 24 of 577 patients (4.2%) in the angiography-guided group (hazard ratio, 1.32; 95% confidence interval, 0.78 to 2.23; P = 0.31). Death occurred in 9 patients (1.5%) in the FFR-guided group and in 10 (1.7%) in the angiography-guided group; nonfatal myocardial infarction in 18 (3.1%) and 10 (1.7%), respectively; and unplanned hospitalization leading to urgent revascularization in 15 (2.6%) and 11 (1.9%), respectively. CONCLUSIONS: In patients with STEMI undergoing complete revascularization, an FFR-guided strategy did not have a significant benefit over an angiography-guided strategy with respect to the risk of death, myocardial infarction, or urgent revascularization at 1 year. However, given the wide confidence intervals for the estimate of effect, the findings do not allow for a conclusive interpretation. (Funded by the French Ministry of Health and Abbott; FLOWER-MI ClinicalTrials.gov number, NCT02943954.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa2104650

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 358

Metadata

Authors
Puymirat, E., Cayla, G., Simon, T., Steg, P. G., Montalescot, G., Durand-Zaleski, I., le Bras, A., Gallet, R., Khalife, K., Morelle, J.-F., Motreff, P., Lemesle, G., Dillinger, J.-G., Lhermusier, T., Silvain, J., Roule, V., Labèque, J.-N., Rangé, G., Ducrocq, G., Cottin, Y., Blanchard, D., Charles Nelson, A., De Bruyne, B., Chatellier, G., & Danchin, N.
Venue
New England Journal of Medicine
Published
2021-07-22
Volume
385
Issue
4
Pages
297-308
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W3163922783
Cited by
358
References
24
FWCI
52.32
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.